Is Carmustine Wafer Implantation in Progressive High-Grade Gliomas a Relevant Therapeutic Option? Complication Rate, Predictors of Complications and Onco-Functional Outcomes in a Series of 53 Cases.

MLA

Gkasdaris, Grigorios, et al. “Is Carmustine Wafer Implantation in Progressive High-Grade Gliomas a Relevant Therapeutic Option? Complication Rate, Predictors of Complications and Onco-Functional Outcomes in a Series of 53 Cases.” Cancers, vol. 16, no. 20, Oct. 2024, p. 3465. EBSCOhost, https://doi.org/10.3390/cancers16203465.

APA

Gkasdaris, G., Berthiller, J., Guyotat, J., Jouanneau, E., Gallet, C., Meyronet, D., Thomas, L., Cartalat, S., Seyve, A., Honnorat, J., Ducray, F., & Picart, T. (2024). Is Carmustine Wafer Implantation in Progressive High-Grade Gliomas a Relevant Therapeutic Option? Complication Rate, Predictors of Complications and Onco-Functional Outcomes in a Series of 53 Cases. Cancers, 16(20), 3465. https://doi.org/10.3390/cancers16203465

Chicago

Gkasdaris, Grigorios, Julien Berthiller, Jacques Guyotat, Emmanuel Jouanneau, Clémentine Gallet, David Meyronet, Laure Thomas, et al. 2024. “Is Carmustine Wafer Implantation in Progressive High-Grade Gliomas a Relevant Therapeutic Option? Complication Rate, Predictors of Complications and Onco-Functional Outcomes in a Series of 53 Cases.” Cancers 16 (20): 3465. doi:10.3390/cancers16203465.